Kelly SackettPrincipal Scientist at Pfizer
Kelly Sackett is a Principal Scientist in Analytical R&D, BioTherapeutics Pharmaceutical Sciences at Pfizer, Groton, CT. He leverages solution NMR approaches toward characterization, process understanding, and method development for various biological drug candidates including glycoconjugate vaccines, small molecule conjugate vaccines and proteins. His is focused on optimizing molecular characterization strategies throughout drug lifecycle. Kelly holds a PhD in Biological Chemistry (2006) from the Weizmann Institute of Science, Rehovot, Israel (lab of Prof. Yechiel Shai). Postdoctoral work (NIH Ruth Kirschstein fellow) was carried out under Prof. David Weliky at Michigan State University.